The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.
Also called NCT04425590
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose supportive care
- Phase
- Phase 2/3
- Enrolled
- 180 participants
- Sponsor
- Duta Wacana Christian University
- Registry
-
NCT04425590
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Indonesia
- Registry status
- Unknown status
Technical summary
Registry record NCT04425590. Randomized; no masking; primary purpose supportive care. Start 2020-04-01 (actual); primary completion 2020-08 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
- Condition
- Ischemic Stroke
- Intervention (Drug)
- DLBS1033
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Statin
- Intervention (Drug)
- Vit B12
- Lead sponsor
- Duta Wacana Christian University
- Collaborator
- Dexa Laboratories Of Biomolecular Science
Record details
- Record id
cardio:ct-nct04425590- Content hash
e4364ac89633b3399b0d4ce6770bca2d4edbd894ac5e9b9b1508754833381317